Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 12
Phase 22
Phase 41

Trial Status

Recruiting1
Other4

Role Distribution

Principal Investigator2
Other Roles3
PI Rate40%

Activity Timeline

Clinical Trials (5)

NCT07648992Phase 4Recruiting
Individualized Application of Anti-Thymocyte Globulin(ATG)in Unrelated Donor Hematopoietic Stem Cell Transplantation
Hematopoietic Stem Cell Transplantation
StudychairStart date: 2025-12-01
NCT07094464Phase 1Active Not Recruiting
Maintenance Therapy With Selinexor and Azacitidine in TP53 Mutant AML/MDS After Transplantation
Allogeneic Hematopoietic Stem Cell TransplantationTP53-mutated MDS and AML
PrincipalinvestigatorStart date: 2025-06-01
NCT07094477Phase 2Active Not Recruiting
Study of Targeted CD22/CD19 CAR-T Therapy for First-line Consolidation of B-cell Lymphoma
Lymphoma
PrincipalinvestigatorStart date: 2025-04-01
NCT07576010Phase 1Active Not Recruiting
Steroids Combined With Ruxolitinib as First-Line Therapy for Grade II Acute Graft-versus-Host Disease
Acute Graft-versus-host Disease
StudychairStart date: 2025-01-17
NCT04778618Phase 2Unknown
Individualized Dose Study of ATG in Haploidentical Hematopoietic Stem Cell Transplantation
Haploidentical Hematopoietic Stem Cell Transplantation
StudychairStart date: 2020-12-01

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Publications (0)

No publications found for this investigator.

Clinical Trials (5)

Showing 5 of 5 trials

NCT07648992Phase 4StudyChair

Individualized Application of Anti-Thymocyte Globulin(ATG)in Unrelated Donor Hematopoietic Stem Cell Transplantation

Hematopoietic Stem Cell Transplantation
Recruiting
NCT07094464Phase 1PrincipalInvestigator

Maintenance Therapy With Selinexor and Azacitidine in TP53 Mutant AML/MDS After Transplantation

Allogeneic Hematopoietic Stem Cell TransplantationTP53-mutated MDS and AML
Active Not Recruiting
NCT07094477Phase 2PrincipalInvestigator

Study of Targeted CD22/CD19 CAR-T Therapy for First-line Consolidation of B-cell Lymphoma

Lymphoma
Active Not Recruiting
NCT07576010Phase 1StudyChair

Steroids Combined With Ruxolitinib as First-Line Therapy for Grade II Acute Graft-versus-Host Disease

Acute Graft-versus-host Disease
Active Not Recruiting
NCT04778618Phase 2StudyChair

Individualized Dose Study of ATG in Haploidentical Hematopoietic Stem Cell Transplantation

Haploidentical Hematopoietic Stem Cell Transplantation
Unknown

All 5 trials loaded